Aligos Therapeutics Inc. Stock Forecast
Big movements in Aligos Therapeutics Inc. stock price on Wednesday moving 10.17% between high and low
(Updated on Apr 24, 2024)
The Aligos Therapeutics Inc. stock price gained 0.656% on the last trading day (Wednesday, 24th Apr 2024), rising from $0.82 to $0.83. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 10.17% from a day low at $0.790 to a day high of $0.87. The price has been going up and down for this period, and there has been a -20.29% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 547 thousand more shares were traded than the day before. In total, 644 thousand shares were bought and sold for approximately $534.08 thousand.
The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $0.764 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 29.06% during the next 3 months and, with a 90% probability hold a price between $0.99 and $1.68 at the end of this 3-month period.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
ALGS Signals & Forecast
There are mixed signals in the stock today. The Aligos Therapeutics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $0.93. On a fall, the stock will find some support from the short-term average at $0.80. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Friday, March 01, 2024, and so far it has fallen -26.64%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Aligos Therapeutics Inc. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.
Support, Risk & Stop-loss for Aligos Therapeutics Inc. stock
Aligos Therapeutics Inc. finds support from accumulated volume at $0.80 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0803 between high and low, or 10.17%. For the last week, the stock has had daily average volatility of 10.01%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (ALGS) For The Upcoming Trading Day Of Thursday 25th
For the upcoming trading day on Thursday, 25th we expect Aligos Therapeutics Inc. to open at $0.83, and during the day (based on 14 day Average True Range), to move between $0.748 and $0.91, which gives a possible trading interval of +/-$0.0814 (+/-9.81%) up or down from last closing price. If Aligos Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 19.63% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $0.80 (3.50%) than the resistance at $0.87 (4.95%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Earnings coming up
Aligos Therapeutics Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.190. We will update the financials statements for Aligos Therapeutics Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 9.94% in the first trading day after earnings release.
Is Aligos Therapeutics Inc. stock A Buy?
Aligos Therapeutics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.
Current score: -2.210 Sell Candidate Unchanged
Predicted Opening Price for Aligos Therapeutics Inc. of Thursday, April 25, 2024
| Fair opening price April 25, 2024 | Current price |
|---|---|
| $0.83 ( 0.0603%) | $0.83 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for ALGS
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.91 | 9.75 % | |
| R2 | 0.88 | 6.05 % | ||
| R1 | 0.86 | 3.76 % | ||
| Current price: | 0.83 | |||
| Support | S1 | 0.799 | -3.64 % | |
| S2 | 0.780 | -5.93 % | ||
| S3 | 0.749 | -9.63 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 0.95 | 14.60 % | |
| R2 | 0.91 | 9.77 % | ||
| R1 | 0.87 | 4.95 % | ||
| Current price | 0.83 | |||
| Support | S1 | 0.80 | -3.50% | |
| S2 | 0.750 | -9.53% | ||
| S3 | 0.690 | -16.77% |
FAQ
Click here for our free guide on how to buy Aligos Therapeutics Inc. Stock.
